Moreover, the dopaminergic degeneration caused by 6-OHDA is followed by changes in the expression of connexin-36.<h4>Conclusions</h4>The use of the GJ blockers directly along the nigrostriatal pathways to control PD motor symptoms is conjectured. The gene discussed is GJD2; the disease is Parkinson disease.